Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential

Bibliography

• BUSHONG SC: An overview of magnetic resonance imaging. Magnetic Resonance Imaging: Physical and Biological Principles (3rd edn) Mosby, St. Louis, MO, USA (2003):3-17.
   Google Scholar
• LIANG ZP, LAUTERBUR PC: Signal generation and detection. Principles of Magnetic Resonance Imaging: A Signal Processing Perspective (1st edn) IEEE Press, Piscataway, NJ, USA (2000):57-105.
   Google Scholar
• LAUFFER RB: Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev. (1987) 87(5):901-927.
   Web of Science ®Google Scholar
• SCHWERT DD, DAVIES JA, RICHARDSON N: Non-gadolinium-based MRI contrast agents. Top. Curr. Chem. (2002) 221:165-199.
   Web of Science ®Google Scholar
• CARAVAN P, ELLISON JJ, MCMURRY TJ, LAUFFER RB: Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, applications. Chem. Rev. (1999) 99(9):2293-2352.
   PubMed Web of Science ®Google Scholar
• TÓTH É, HELM L, MERBACH AE: Relaxivity of gadolinium(III) complexes: theory and mechanism. In: The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging (1st edn) Merbach AE, Tóth É, (Eds.), John Wiley & Sons, Ltd., West Sussex, England (2001):45-119.
   Google Scholar
• BIAGI BA, ENYEART JJ: Gadolinium blocks low- and high-threshold calcium currents in pituitary cells. Am. J. Physiol. (1990) 259(3):C515-C520.
   PubMed Web of Science ®Google Scholar
• LANSMAN JB: Blockade of current through single calcium channels by trivalent lanthanide cations: effect of ionic radius on the rates of ion entry and exit. J. Gen. Physiol. (1990) 95(4):679-696.
   PubMed Web of Science ®Google Scholar
• DARNALL DW, BIRNBAUM ER: Lanthanide ions activate α-amylase. Biochemistry (1973) 12(18):3489-3491.
   PubMed Web of Science ®Google Scholar
• HALEY TJ, RAYMOND K, KOMESU N, UPHAM HC: Toxological and pharmacological effects of gadolinium and samarium chlorides. Br. J. Pharmacol. (1961) 17:526-532.
   Web of Science ®Google Scholar
• WIENMANN HJ, BRASCH RC, PRESS WR, WESBEY GE: Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am. J. Roentgenol (1984) 142(3):619-624.
   PubMed Web of Science ®Google Scholar
• CACHERIS WP, QUAY SC, ROCKLAGE SM: The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn. Reson. Imaging (1990) 8(4):467-481.
   PubMed Web of Science ®Google Scholar
• RUNGE VM, CLANTON JA, PRICE AC et al.: The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruption. Magn. Reson. Imaging (1985) 3(1):43-55.
   PubMedGoogle Scholar
• TOFTS PS, KERMODE AG: Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging: 1. Fundamental concepts. Magn. Reson. Med. (1991) 17(2):357-367.
   PubMed Web of Science ®Google Scholar
• LARSSON HB, TOFTS PS: Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning – a comparison of methods. Magn. Reson. Med. (1992) 24(1):174-176.
   PubMed Web of Science ®Google Scholar
• MILLER DH, GROSSMAN RI, REINGOLD SC, MCFARLAND HF: The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain (1998) 121:3-24.
   PubMed Web of Science ®Google Scholar
• CLARKSON RB: Blood-pool MRI contrast agents: properties and characterization. Top. Curr. Chem. (2002) 221:201-235.
   Web of Science ®Google Scholar
• TWEEDLE MF, EATON SM, ECKELMAN WC et al.: Comparative Chemical structure and pharmacokinetics of MRI contrast agents. Invest. Radiol. (1988) 23(Suppl. 1):S236-S239.
   PubMed Web of Science ®Google Scholar
• BARNHART JL, KUHNERT N, BAKAN DA, BERK RN: Biodistribution of GdCl3 and Gd-DTPA and their influence on proton magnetic relaxation in rat tissues. Magn. Reson. Imaging (1987) 5(3):221-231.
   PubMed Web of Science ®Google Scholar
• HO VB, FOO TKF, CZUM JM, MARCOS H, CHOYKE PL, KNOPP MV: Contrast-enhanced magnetic resonance angiography: technical considerations for optimized clinical implementation. Top. Magn. Reson. Imaging (2001) 12(4):283-299.
   PubMedGoogle Scholar
• MAEDA H, WU J, SAWA T, MATSUMURA Y, HORI K: Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release (2000) 65(1-2):271-284.
   PubMed Web of Science ®Google Scholar
• KOPECEK J, KOPECKOVA P, MINKO T, LU ZR, PETERSON CM: Water soluble polymers in tumor targeted delivery. J. Control. Release (2001) 74(1-3):147-158.
   PubMed Web of Science ®Google Scholar
• OGAN MD, SCHMIEDL U, MOSELELY ME, GRODD W, PAAJANEN H, BRASCH RC: Albumin labeled with Gd-DTPA an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest. Radiol. (1987) 22(8):665-671.
   PubMed Web of Science ®Google Scholar
• SHERRY AD, CACHERIS WP, KUAN KT: Stability constants for Gd3+ binding to model GTPA-conjugates and DTPA-proteins: use as magnetic resonance contrast agents. Magn. Reson. Med. (1988) 8(2):180-190.
   PubMed Web of Science ®Google Scholar
• PAAJANEN H, RIESTO T, HEMMILÄ I, KOMU M, NIEMI P, KORMANO M: Proton relaxation enhancement of albumin, immunoglobin G, and fibrinogen labeled with Gd-DTPA. Magn. Reson. Med. (1990) 13(1):38-43.
   PubMed Web of Science ®Google Scholar
• CORSI DM, ELST VL, MULLER RN, VAN BEKKUM H, PETERS JA: Inulin as a carrier for contrast agents in magnetic resonance imaging. Chem. Eur. J. (2001) 7:64-71.
   PubMed Web of Science ®Google Scholar
• LEBDUSKOVA P, KOTEK J, HERMANN P et al.: A gadolinium(III) complex of a carboxylic-phosphorus acid derivative of diethylenetriamine covalently bound to inulin, a potential macromolecular MRI contrast agent. Bioconjugate Chem. (2004) 15(4):881-889.
   PubMed Web of Science ®Google Scholar
• DALDRUP H, SHAMES DM, WENDLAND M et al.: Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am. J. Roentgenol. (1998) 171(4):941-949.
   PubMed Web of Science ®Google Scholar
• SCHMIEDL U, OGAN M, PAAJANEN H et al.: Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for mr imaging: biodistribution and imaging and imaging studies. Radiology (1987) 162(1):205-210.
   PubMed Web of Science ®Google Scholar
• BAXTER AB, MELNIKOFF S, STITES DP, BRASCH RC: Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging: induction and characterization of antibodies in animals. Invest. Radiol. (1991) 26(12):1035-1040.
   PubMed Web of Science ®Google Scholar
• BRASCH R, PHAM C, SHAMES D et al.: Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J. Magn. Reson. Imaging (1997) 7(1):68-74.
   PubMed Web of Science ®Google Scholar
• BRASCH RC, SCHAMES DM, COHEN FM et al.: Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas. Invest. Radiol. (1994) 29(Suppl. 2):S8-S11.
   PubMed Web of Science ®Google Scholar
• WANG Z, SU MY, NALCIOGLU O: Measurement of tumor vascular volume and mean microvascular random flow velocity magnitude by dynamic Gd-DTPA-albumin enhanced and diffusion-weighted MRI. Magn. Reson. Med. (1998) 40(3):397-404.
   PubMed Web of Science ®Google Scholar
• BRASCH RC, DALDRUP H, SHAMES D, WENDLAND M, OKUHATA Y, ROSENAU W: Macromolecular contrast media-enhanced MRI estimation of microvascular permeability correlate with histopathologic tumor grade. Acad. Radiol. (1998) 5(Suppl. 1):S2-S5.
   PubMed Web of Science ®Google Scholar
• OKUHATA Y, BRASCH RC, PHARM C et al.: Tumor blood volume assays using contrast-enhanced magnetic resonance imaging: regional heterogeneity and postmortem artifacts. J. Magn. Reson. Imaging (1999) 9(5):685-690.
   PubMed Web of Science ®Google Scholar
• PATHAK AP, ARTEMOV D, WARD BD, JACKSON DG, NEEMAN M, BHUJWALLA ZM: Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imaging. Cancer Res. (2005) 65(4):1425-1432.
   PubMed Web of Science ®Google Scholar
• MEYER D, SCHAFFER M, CHAMBON C, BEAUTE S: Paramagnetic dextrans as magnetic resonance blood pool tracers. Invest. Radiol. (1994) 29(Suppl. 2):S90-S92.
   PubMed Web of Science ®Google Scholar
• GIBBY WA, BOGDAN A, OVITT TW: Cross-linked DTPA polysaccharides for magnetic resonance imaging: synthesis and relaxation properties. Invest. Radiol. (1989) 24(4):302-309.
   PubMed Web of Science ®Google Scholar
• LOUBEYRE P, CANET E, ZHAO S, BENDERBOUS S, AMIEL M, DIDIER R: Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiograhy: experimental study in rabbits. Invest. Radiol. (1996) 31(5):288-293.
   PubMed Web of Science ®Google Scholar
• SIRLIN CB, VERA DR, CORBEIL JA, CABALLERO MB, BUXTON RB, MATTREY RF: Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. Acad. Radiol. (2004) 11(12):1361-1369.
   PubMed Web of Science ®Google Scholar
• CANET EP, CASALI C, DESENFANT A et al.: Kinetic characterization of CMD-A2-Gd-DOTA as an intravascular contrast agent for myocardial perfusion measurement with MRI. Magn. Reson. Med. (2000) 43(3):403-409.
   PubMed Web of Science ®Google Scholar
• KROFT LJM, DOORNBOS J, BENDERBOUS S, DE ROOS A: Equilibrium phase MR angiography of the aortic arch and abdominal vasculature with the blood pool contrast agent CMD-A2-Gd-DOTA in pigs. J. Magn. Reson. Imaging (1999) 9(6):777-785.
   PubMed Web of Science ®Google Scholar
• KROFT LJM, DOORNBOS J, VAN DER GEEST RJ, DE ROOS A: Blood pool contrast agent CMD-A2-Gd-DOTA-enhanced MR imaging of infarcted myocardium in pigs. J. Magn. Reson. Imaging (1999) 10(2):170-177.
   PubMed Web of Science ®Google Scholar
• BLUSTAJN J, CUENOD CA, CLEMENT O, SIAUVE N, VUILLEMIN-BODAGHI V, FRIJA G: Measurement of liver blood volume using a macromolecular MRI contrast agent at equilibrium. Magn. Reson. Imaging (1997) 15(4):415-421.
   PubMed Web of Science ®Google Scholar
• SIAUVE N, CLÉMENT O, CUÉNOD CA, BENDERBOUS S, FRIJA G: Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications. Magn. Reson. Imaging (1996) 14(4):380-390.
   Google Scholar
• SIEVING PF, WATSON AD, ROCKLAGE SM: Preparation and characterization of paramagnetic polychelates and their protein conjugates. Bioconjugate. Chem. (1990) 1(1):65-71.
   PubMed Web of Science ®Google Scholar
• KORNGUTH S, ANDERSON M, TURSKI P et al.: Glioblastoma multiforme: MR imaging at 1.5 and 9.4 T after injection of polylysine-DTPA-Gd in rats. AJNR Am. J. Neuroradiol. (1990) 11(2):313-318.
   PubMed Web of Science ®Google Scholar
• MARCHAL G, BOSMANS H, VAN HECKE P et al.: MR angiography with gadopentate dimeglumine-polylysine: evaluation in rabbits. AJR Am. J. Roentgenol. (1990) 155(2):407-411.
   PubMed Web of Science ®Google Scholar
• SCHUHMANN-GIAMPIERI G, SCHMITT-WILLICH H, FRENZEL T, PRESS WR, WIENMANN HJ: In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest. Radiol. (1991) 26(11):969-974.
   PubMed Web of Science ®Google Scholar
• AIME S, BOTTA M, CRICH SG, GIOVENZANA G, PALMISANO G, SISTI M: Novel paramagnetic macromolecular complexes derived from the linkage of a macrocyclic Gd(III) complex to polyamino acids through a squaric acid moiety. Bioconjugate Chem. (1999) 10(2):192-199.
   PubMed Web of Science ®Google Scholar
• VEXLER VS, CLÉMENT O, SCHMITT-WILLICH H, BRASCH RC: Effect of varying the molecular weight of the mr contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns. J. Magn. Reson. Imaging (1994) 4(3):381-388.
   PubMed Web of Science ®Google Scholar
• KNOLLMANN FD, SORGE R, MÜHLER A et al.: Hemodynamic tolerance of intravascular contrast agents for magnetic resonance imaging. Invest. Radiol. (1997) 32(12):755-762.
   PubMed Web of Science ®Google Scholar
• OPSAHL LR, UZGIRIS EE, VERA DR: Tumor imaging with a macromoelcular paramagnetic contrast agent: gadopentate dimeglumine-polylysine. Acad. Radiol. (1995) 2(9):762-767.
   PubMed Web of Science ®Google Scholar
• BERTHEZÈNE Y, VEXLER V, JEROME H, SIEVERS R, MOSELEY ME, BRASCH RC: Differentiation of capillary leak and hydrostatic pulmonary edema with macromolecular MR imaging contrast agent. Radiology (1991) 181(3):773-777.
   PubMed Web of Science ®Google Scholar
• BERTHEZÈNE Y, VEXLER V, PRICE DC et al.: Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent polylysine-gadolinium-DTPA40. Invest. Radiol. (1991) 27(5):346-351.
   Web of Science ®Google Scholar
• LIM TH, LEE DH, KIM YH et al.: Occlusive and reperfused myocardial infarction: detection by using MR imaging with gadolinium polylysine enhancement. Radiology (1993) 189(3):765-768.
   PubMed Web of Science ®Google Scholar
• SAEED M, WENDLAND MF, MASUI T et al.: Myocardial infarction: assessment with an intravascular MR contrast medium: work in progress. Radiology (1991) 180(1):153-160.
   PubMed Web of Science ®Google Scholar
• LADD DL, HOLLISTER R, PING X et al.: Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties. Bioconjugate Chem. (1999) 10(3):361-370.
   PubMed Web of Science ®Google Scholar
• DESSER TS, RUBIN DL, MULLER HH et al.: Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weight. J. Magn. Reson. Imaging (1994) 4(3):467-472.
   PubMed Web of Science ®Google Scholar
• KELLAR KE, HENRICHS PM, HOLLISTER R, KOENIG SH, ECK J, WEI D: High relaxivity linear Gd(DTPA)-polymer conjugates: the role of hydrophobic interactions. Magn. Reson. Med. (1997) 38(5):712-716.
   PubMed Web of Science ®Google Scholar
• UNGER EC, SHEN D, WU G, STEWART L, MATSUNAGA TO, TROUARD TP: Gadolinium-containing copolymeric chelates – a new potential MRI contrast agent. Magn. Reson. Mater. Phys. Biol. Med. (1999) 8(3):154-162.
   Google Scholar
• TÓTH E, VAN UFFELEN I, HELM L et al.: Gadolinium-based linear polymer with temperature-independent proton relaxivities: a unique interplay between the water exchange and rotational contributions. Magn. Reson. Chem. (1998) 36(S1):S125-S134.
   Web of Science ®Google Scholar
• DESSER TS, RUBIN DL, MULLER H, MCINTIRE GL, BACON ER, HOLLISTER KR: Interstitial MR and CT lymphography with Gd-DTPA-co-α,ω,-diaminopeg(1450) and Gd-DTPA-co-1,6-diaminohexane polymers: preliminary experience. Acad. Radiol. (1999) 6(2):112-118.
   PubMed Web of Science ®Google Scholar
• BONK RT, SCHMIEDL UP, YUAN C, NELSON JA, BLACK CDV, LADD DL: Time-of-flight MR angiography with Gd-DTPA hexamethylene diamine co-polymer blood pool contrast agent: comparison of enhanced MRA and conventional angiography for arterial stenosis induced in rabbits. J. Magn. Reson. Imaging (2000) 11(6):638-646.
   PubMed Web of Science ®Google Scholar
• BJØNÆS I, ROFSTAD EK: Transvascular and interstitial transport of a 19 kDa linear molecule in human melanoma xenografts measured by contrast-enhanced magnetic resonance imaging. J. Magn. Reson. Imaging (2001) 14(5):608-616.
   PubMed Web of Science ®Google Scholar
• KRAUSE W, HACKMANN-SCHLICHTER N, MAIER FK, MÜLLER R: Dendrimers in diagnostics. Top. Curr. Chem. (2001) 210:261-307.
   Web of Science ®Google Scholar
• NICOLLE GM, TÓTH E, SCHMITT-WILLICH H, RADÜCHEL B, MERBACH AE: The impact of rigidity and water exchange on the relaxivity of a dendritic MRI contrast agent. Chem. Eur. J. (2002) 8(5):1040-1048.
   PubMed Web of Science ®Google Scholar
• ADAM G, NEUERBERG J, SPÜNTRUP E, MÜHLER A, SCHERER K, GÜNTHER RW: Gd-DTPA-cascade-polymer: potential blood pool contrast agent for MR imaging. J. Magn. Reson. Imaging (1994) 4(3):462-466.
   PubMed Web of Science ®Google Scholar
• WIENER EC, BRECHBIEL MW, BROTHER H et al.: Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn. Reson. Med. (1994) 31(1):1-8.
   PubMed Web of Science ®Google Scholar
• FISCHER M, VÖGTLE F: Dendrimers: from design to application – a progress report. Angew. Chem. Int. Ed. (1999) 38(7):884-905.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, BRECHBIEL MW: Nano-sized MRI contrast agents with dendrimer cores. Adv. Drug Deliv. Rev. (2005) 57(15):2271-2286.
   PubMed Web of Science ®Google Scholar
• SATO N, KOBAYASHI H, HIRAGA A et al.: Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores. Magn. Reson. Med. (2001) 46(6):1169-1173.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, KAWAMOTO S, JO SK, BRYANT HL JR, BRECHBIEL MW, STAR RA: Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Bioconjugate Chem. (2003) 14(2):388-394.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, KAWAMOTO S, CHOYKE PL et al.: Comparison of dendrimer-based macrmolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn. Reson. Med. (2003) 50(4):758-766.
   PubMed Web of Science ®Google Scholar
• LAUS S, SOUR A, RULOFF R, TÓTH E, MERBACH AE: Rotational dynamics account for pH-dependent relaxivities of PAMAM dendrimeric, Gd-based potential MRI contrast agents. Chem. Eur. J. (2005) 11(10):3064-3076.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, SATO N, KAWAMOTO S et al.: Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer. Bioconjugate Chem. (2001) 12(1):100-107.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, KAWAMOTO S, SAGA T et al.: Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core. Magn. Reson. Med. (2001) 46(4):795-802.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, SAGA T, KAWAMOTO S et al.: Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)64. Cancer Res. (2001) 61(13):4966-4970.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, SATO N, KAWAMOTO S et al.: 3D MR Angiography of intratumoral vasculature using a novel macromolecular MR contrast agent. Magn. Reson. Med. (2001) 46(3):579-585.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, KAWAMOTO S, SAGA T et al.: Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents. J. Magn. Reson. Imaging (2001) 14(6):705-713.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, SHIRAKAWA K, KAWAMOTO S et al.: Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)256. Cancer Res. (2002) 62(3):860-866.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, KAWAMOTO S, SAKAI Y et al.: Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J. Natl. Cancer Inst. (2004) 96(9):703-708.
   PubMed Web of Science ®Google Scholar
• DONG Q, HURST DR, WEINMANN HJ, CHENEVERT TL, LONDY FJ, PRINCE MR: Magnetic resonance angiography with gadomer-17: an animal study. Invest. Radiol. (1998) 33(9):699-708.
   PubMed Web of Science ®Google Scholar
• DALDRUP-LINK HE, SHAMES DM, WENDLAND M et al.: Comparison of gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging. Acad. Radiol. (2000) 7(11):934-944.
   PubMed Web of Science ®Google Scholar
• TILCOCK C, UNGER E, CULLIS P, MACDOUGALL P: Liposomal Gd-DTPA: preparation and characterization of relaxivity. Radiology (1989) 171(1):77-80.
   PubMed Web of Science ®Google Scholar
• UNGER E, TILCOCK C, AHKONG QF, FRITZ T: Paramagnetic liposomes as magnetic resonance contrast agents. Invest. Radiol. (1990) 25(Suppl. 1):S65-S66.
   PubMed Web of Science ®Google Scholar
• TURSKI P, KALINKE T, STROTHER L, PERMAN W, SCOTT G, KORNGUTH S: Magnetic resonance imaging of rabbit brain after intercarotid injection of large multivesicular liposomes containing paramagnetic metals and DTPA. Magn. Reson. Med. (1988) 7(2):184-196.
   PubMed Web of Science ®Google Scholar
• UNGER E, SHEN DK, WU G, FRITZ T: Liposomes as MR contrast agents: pros and cons. Magn. Reson. Med. (1991) 22(2):304-308.
   PubMed Web of Science ®Google Scholar
• UNGER EC, MACDOUGALL P, CULLIS P, TILCOCK C: Liposomal Gd-DTPA: effect of encapsulation on enhancement of hepatoma model by MRI. Magn. Reson. Imaging (1989) 7(4):417-423.
   PubMed Web of Science ®Google Scholar
• UNGER E, CARDENAS D, ZERELLA A, FAJARDO LL, TILCOCK C: Biodistribution and clearance of liposomal gadolilinium-DTPA. Invest. Radiol. (1990) 25(6):638-644.
   PubMed Web of Science ®Google Scholar
• FRITZ T, UNGER E, WILSON-SANDERS S, AHKONG QF, TILCOCK C: Detailed toxicity studies of liposomal gadolinium-DTPA. Invest. Radiol. (1991) 26(11):960-968.
   PubMed Web of Science ®Google Scholar
• KABALKA GW, BUONOCORE E, HUBNER K, DAVIS M, HUANG L: Gadolinium-labeled liposomes containing paramagnetic amphipathic agents: targeted MRI contrast agents for the liver. Magn. Reson. Med. (1988) 8(1):89-95.
   PubMed Web of Science ®Google Scholar
• KABALKA GW, DAVIS MA, BUONOCORE E, HUBNER L, HOLMBERG E, HUANG L: Gd-labeled liposomes containing amphipathic agents for magnetic resonance imaging. Invest. Radiol. (1990) 25(Suppl. 1):S63-S64.
   PubMed Web of Science ®Google Scholar
• KABALKA GW, DAVIS MA, HOLMBERG E, MARUYAMA K, HUANG L: Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: targeted MRI contrast enhancement agents for the liver. Magn. Reson. Imaging (1991) 9(3):373-377.
   PubMed Web of Science ®Google Scholar
• NICOLLE G, TÓTH E, EISENWIENER KP, MÄCKE HR, MERBACH AE: From monomers to micelles: investigation of the parameters influencing proton relaxivity. J. Biol. Inorg. Chem. (2002) 7(7-8):757-769.
   PubMed Web of Science ®Google Scholar
• TOURNIER H, HYACINTHE R, SCHNEIDER M: Gadolinium-containing mixed micelle formulations: a new class of blood pool MRI/MRA contrast agents. Acad. Radiol. (2002) 9(Suppl. 1):S20-S28.
   PubMed Web of Science ®Google Scholar
• UNGER EC, TOTTY WG, NEUFELD DM et al.: Magnetic resonance imaging using gadolinium labeled monoclonal antibody. Invest. Radiol. (1985) 20(7):693-700.
   PubMed Web of Science ®Google Scholar
• ANDERSON-BERG WT, STRAND M, LEMPERT TE, ROSENBAUM AE, JOSEPH PM: Nuclear magnetic resonance and gamma camera tumor imaging using gadolinium labeled monoclonal antibodies. J. Nucl. Med. (1986) 27(6):829-833.
   PubMed Web of Science ®Google Scholar
• MULDER WJM, STRIJKERS GJ, GRIFFIOEN AW et al.: A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjugate Chem. (2004) 15(4):799-806.
   PubMed Web of Science ®Google Scholar
• ACCARDO A, TESAURO D, ROSCIGNO P et al.: Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI. J. Am. Chem. Soc. (2004) 126(10):3097-3107.
   PubMed Web of Science ®Google Scholar
• GOHR-ROSENTHAL S, SCHMITT-WILLICH H, EBERT W, CONRAD J: The demonstration of human tumors on nude mice using gadolinium-labeled monoclonal antibodies for magnetic resonance imaging. Invest. Radiol. (1993) 28(9):789-795.
   PubMed Web of Science ®Google Scholar
• CURTET C, MATON F, HAVET T et al.: Polylysine-Gd-DTPAn and polylysine-Gd-DOTAn coupled to anti-CEA F(ab’)2 fragments as potential immunocontrast agents. Relaxometry, biodistribution, and magnetic resonance imaging in nude mice grafted with human colorectal carcinoma. Invest Radiol. (1998) 33(10):752-761.
   PubMed Web of Science ®Google Scholar
• SIPKINS DA, CHERESH DA, KAZEMI MR, NEVIN LM, BEDNARSKI MD, LI KC: Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging. Nat. Medicine (1998) 4(5):623-626.
   PubMed Web of Science ®Google Scholar
• ANDERSON SA, RADER RK, WESTLIN WF et al.: Magnetic resonance contrast enhancement of neovasculature with avb3-targeted nanoparticles. Magn. Reson. Med. (2000) 44(3):433-439.
   PubMed Web of Science ®Google Scholar
• MULDER WJM, STRIJKERS GJ, HABETS JW et al.: MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J. (2005) 19(14):2008-2010.
   PubMed Web of Science ®Google Scholar
• LIPINSKI MJ, AMIRBEKIAN V, FIAS JC et al.: MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn. Reson. Med. (2006) 56(3):601-610.
   PubMed Web of Science ®Google Scholar
• AMIRBEKIAN V, LIPINSKI MJ, BRILEY-SAEBO KC et al.: Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. PNAS (2007) 104(3):961-966.
   PubMed Web of Science ®Google Scholar
• YU X, SONG SK, CHEN J et al.: High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn. Reson. Med. (2000) 44(6):867-872.
   PubMed Web of Science ®Google Scholar
• KROFT LJM, DE ROOS A: Blood pool contrast agents for cardiovascular MR imaging. J. Magn. Reson. Imaging (1999) 10(3):395-403.
   PubMed Web of Science ®Google Scholar
• FRANANO NF, EDWARDS WB, WELCH MJ, BRECHBIEL MW, GANSOW OA, DUNCAN JR: Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivo. Magn. Reson. Imaging (1995) 13(2):201-214.
   PubMed Web of Science ®Google Scholar
• WANG SJ, BRECHBIEL MW, WIENER EC: Characteristics of a new MRI contrast agent prepared from polypropyleneimine dendrimers, generation 2. Invest. Radiol. (2003) 38(10):662-668.
   PubMed Web of Science ®Google Scholar
• BRYANT HL JR, JORDAN EK, BULTE JWM, HERYNEK V, FRANK JA: Pharmacokinetics of a high-generation dendrimer-Gd-DOTA. Acad. Radiol. (2002) 9(Suppl. 1):S29-S33.
   PubMed Web of Science ®Google Scholar
• HELBICH TH, GOSSMAN A, MARESKI PA et al.: A new polysaccharide macromolecular contrast agent for MR imaging: biodistribution and imaging characteristics. J. Magn. Reson. Imaging (2000) 11(6):694-701.
   PubMed Web of Science ®Google Scholar
• MISSELWITZ B, SCHMITT-WILLICH H, EBERT W, FRANZEL T, WEINMANN HJ: Pharmacokinetic of gadomer-17, a new dendritic magnetic resonance contrast agent. Magn. Reson. Mater. Phys. Biol. Med. (2001) 12(2-3):128-134.
   Google Scholar
• COROT C, PORT M, RAYNAL I et al.: Physical, chemical, and biologic evaluations of P760: a new gadolinium complex characterized by a low rate of interstitial diffusion. J. Magn. Reson. Imaging (2000) 11(2):182-191.
   PubMed Web of Science ®Google Scholar
• PORT M, COROT C, RAYNAL I et al.: Physical and biological evaluation of P792, a rapid-clearance blood-pool agent for magnetic resonance imaging. Invest. Radiol. (2001) 36(8):445-454.
   PubMed Web of Science ®Google Scholar
• DALDRUP-LINK HE, SHAMES DM, WENDLAND M et al.: Comparison of gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging. Acad. Radiol. (2000) 7(11):934-944.
   PubMed Web of Science ®Google Scholar
• TURETSCHECK K, FLOYD E, SHAMES DM et al.: Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology. Magn. Reson. Med. (2001) 45(5):880-886.
   PubMed Web of Science ®Google Scholar
• BOGDANOV AA JR, WEISSLEDER R, FRANK HW et al.: A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology (1993) 187(3):701-706.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, KAWAMOTO S, SAGA T et al.: Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents. Magn. Reson. Med. (2001) 46(4):781-788.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, SATO N, KAWAMOTO S et al.: Novel intravascular macromolecular MRI contrast agent with generation-4 polyamidoamine dendrimer core: accelerated renal excretion with coinjection of lysine. Magn. Reson. Med. (2001) 46(3):457-464.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI H, KAWAMOTO S, STAR RA, WALDMANN TA, BRECHBIEL MW, CHOYKE PL: Activated clearance of a biotinylated macromolecular MRI contrast agent from the blood pool using an avidin chase. Bioconjugate Chem. (2003) 14(5):1044-1047.
   PubMed Web of Science ®Google Scholar
• AYYAGARI AL, ZHANG X, GHAGHADA KB, ANNAPRAGADA A, HU X, BELLAMKONDA RV: Long-circulationg liposomal contrast agents for magnetic resonance imaging. Magn. Reson. Med. (2006) 55(5):1023-1029.
   PubMed Web of Science ®Google Scholar
• MARTIN VV, RALSTON WH, HYNES MR, KEANA JFW: Gadolinium (III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents. Bioconjugate Chem. (1995) 6(5):616-623.
   PubMed Web of Science ®Google Scholar
• LAUFFER RB, PARMELEE DJ, OUELLET HS et al.: MS-325: A small-molecule vascular imaging agent for magnetic resonance imaging. Acad. Radiol. (1996) 3(Suppl. 2):S356-S358.
   PubMed Web of Science ®Google Scholar
• CARAVAN P, CLOUTIER NJ, GREENFIELD MT et al.: The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J. Am. Chem. Soc. (2002) 124(12):3152-3162.
   PubMed Web of Science ®Google Scholar
• CARAVAN P, CUMUZZI C, CROOKS W, MCMURRY TJ, CHOPPIN GR, WOULFE SR: Thermodynamic stability and kinetic inertness of MS-325, a new blood pool agent for magnetic resonance imaging. Inorg. Chem. (2001) 40(9):2170-2176.
   PubMed Web of Science ®Google Scholar
• LIN W, ABENDSCHEIN DR, CELIK A et al.: Intravascular contrast agent improves magnetic resonance angiography of carotid arteries in minipigs. J. Magn. Reson. Imaging (1997) 7(6):963-971.
   PubMed Web of Science ®Google Scholar
• LAUFFER RB, PARMELEE DJ, DUNHAM SU et al.: MS-325: albumin-targeted contrast agent for MR angiography. Radiology (1998) 207(2):S29-S38.
   Google Scholar
• GRIST TM, KOROSEC FR, PETERS DC et al.: Steady state and dynamic MR angiography with MS-325: initial experience in humans. Radiology (1998) 207(2):539-544.
   PubMed Web of Science ®Google Scholar
• RAPP JH, WOLFF SD, QUINN SF et al.: aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography – multicenter comparative Phase III study. Radiology (2005) 236(1):71-78.
   PubMed Web of Science ®Google Scholar
• TURETSCHEK K, FLOYD E, HELBICH T et al.: MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology. J. Magn. Reson. Imaging (2001) 14(3):237-242.
   PubMed Web of Science ®Google Scholar
• DE HAËN C, ANELLI PL, LORUSSO V et al.: Gadocoletic acid trisodium salt (B22956/1) a new blood pool magnetic resonance contrast agent with application in coronary angiography. Invest. Radiol. (2006) 41(3):279-291.
   PubMed Web of Science ®Google Scholar
• CAVAGNA FM, LORUSSO V, ANELLI PL, MAGGIONI F, DE HAËN C: Preclinical profile and clinical potential of gadocoletic acid trisodium salt (B22956/1) a new intravascular contrast medium for MRI. Acad. Radiol. (2002) 9(Suppl. 2):S491-S494.
   PubMed Web of Science ®Google Scholar
• LA NOCE A, STOELBEN S, SCHEFFLER K et al.: B22956/1, a new intravascular contrast agent for MRI: first administration to humans – preliminary results. Acad. Radiol. (2002) 9(Suppl. 2):S404-S406.
   PubMed Web of Science ®Google Scholar
• LU ZR, MOHS AM, ZONG Y, FENG Y: Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents. Int. J. Nanomed. (2006) 1(1):31-40.
   PubMed Web of Science ®Google Scholar
• LU ZR, PARKER DL, GOODRICH KC, WANG X, DALLE JG, BUSWELL HR: Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI. Magn. Reson. Med. (2004) 51(1):27-34.
   PubMed Web of Science ®Google Scholar
• ZONG Y, WANG X, GOODRICH KC, MOHS AM, PARKER DL, LU ZR: Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice. Magn. Reson. Med. (2005) 53(4):835-842.
   PubMed Web of Science ®Google Scholar
• MOHS AM, WANG X, GOODRICH KC, ZONG Y, PARKER DL, LU ZR: PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agents for MR imaging. Bioconjugate Chem. (2004) 15(6):1424-1430.
   PubMed Web of Science ®Google Scholar
• MOHS AM, ZONG Y, GUO J, PARKER DL, LU ZR: PEG-g-poly(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI. Biomacromolecules (2005) 6(4):2305-2311.
   PubMed Web of Science ®Google Scholar
• KANESHIRO TL, KE T, JEONG EK, PARKER DL, LU ZR: Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for blood pool MR imaging. Pharm. Res. (2006) 23(6):1285-1294.
   PubMed Web of Science ®Google Scholar
• WANG X, FENG Y, KE T, SCHABEL M, LU ZR: Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent. Pharm. Res. (2005) 22(4):596-602.
   PubMed Web of Science ®Google Scholar
• FENG Y, ZONG Y, KE T, JEONG EK, PARKER DL, LU ZR: Pharmacokinetics, biodistribution, and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a rat model. Pharm. Res. (2006) 23(8):1736-1742.
   PubMed Web of Science ®Google Scholar
• NGUYEN TD, SPINCE-MAILLE P, VAIDYA A, PRINCE MR, LU ZR, WANG Y: Contrast-enhanced magnetic resonance angiography with biodegradable (Gd-DTPA)-cystamine copolymers: comparison with MS-325 in a swine model. Mol. Pharm. (2006) 3(5):558-565.
   PubMedGoogle Scholar